According to the American consumer group the Center for Science in the Public Interest (CSPI), Coca-Cola have made a range of claims about Vitaminwater that go beyond those allowed by the Food and Drug Administration.
The CSPI says Vitaminwater is marketed as a healthful alternative to soda by the use of health buzz words as 'defense,' 'rescue,' 'energy' and 'endurance on the labelling and they have issued a class action lawsuit against Coca-Cola about the matter.
The CSPI says Coca-Cola also claims the drinks reduce the risk of chronic disease and eye disease, promote healthy joints and support immune function, when in fact the 33 grams of sugar in each bottle of Vitaminwater do more to promote obesity, diabetes and other health problems than the vitamins in the drinks do to perform the advertised benefits listed on the bottles.
Coca-Cola has dismissed the suit as ridiculous but the CSPI says it hopes the company will change its marketing practices and would like to see consumers reimbursed.
This latest lawsuit comes just weeks after the company was warned by U.S. health regulators about the way it markets another product.
Coca-Cola was criticised by the FDA in December over claims that Diet Coke Plus included a variety of vitamins and minerals which was a violation of U.S. policy against marketing soda and other snack foods as more nutritious.
According to the CSPI the VitaminWater labels' claims cross the line and are an outright fraud.
CSPI says VitaminWater contains between 0% to 1% juice, even though the full names of the drinks include "endurance peach mango" and "focus kiwi strawberry" and "xxx blueberry pomegranate acai" - even though they contain no blueberry, pomegranate, or acai juice.
The other juices contain no cranberry, grapefruit, dragon fruit, peach, mango, kiwi, or strawberry juice.
PENN Medicine is a $3.6 billion enterprise dedicated to the related missions of medical education, biomedical research, and excellence in patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.
Penn's School of Medicine is currently ranked #4 in the nation in U.S.News & World Report's survey of top research-oriented medical schools; and, according to most recent data from the National Institutes of Health, received over $379 million in NIH research funds in the 2006 fiscal year. Supporting 1,700 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.
The University of Pennsylvania Health System (UPHS) includes its flagship hospital, the Hospital of the University of Pennsylvania, rated one of the nation's top ten "Honor Roll" hospitals by U.S.News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center. In addition UPHS includes a primary-care provider network; a faculty practice plan; home care, hospice, and nursing home; three multispecialty satellite facilities; as well as the Penn Medicine at Rittenhouse campus, which offers comprehensive inpatient rehabilitation facilities and outpatient services in multiple specialties.
The Abramson Cancer Center (ACC) of the University of Pennsylvania is a national leader in cancer research, patient care, and education. The pre-eminent position of the Cancer Center is reflected in its continuous designation as a Comprehensive Cancer Center by the National Cancer Institute for 30 years, one of 39 such Centers in the United States. The ACC is dedicated to innovative and compassionate cancer care. The clinical program, composed of a dedicated staff of physicians, nurse practitioners, nurses, social workers, physical therapists, nutritionists and patient support specialists, currently sees over 50,000 outpatient visits, 3400 inpatient admissions, and provides over 25,000 chemotherapy treatments, and more than 65,000 radiation treatments annually. Not only is the ACC dedicated to providing state-of-the-art cancer care, the latest forms of cancer prevention, diagnosis, and treatment are available to our patients through clinical themes that developed in the relentless pursuit to eliminate the pain and suffering from cancer. In addition, the ACC is home to the 400 research scientists who work relentlessly to determine the pathogenesis of cancer. Together, the faculty is committed to improving the prevention, diagnosis and treatment of cancer.
uphs.upenn/